{
  "timestamp": "20250104_032043",
  "model": "gpt-4-turbo",
  "interaction_type": "answer_with_CoT",
  "question_id": "602a9994",
  "question_text": "Propronolol is useful in all except -",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert using chain-of-thought reasoning."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n            You are a medical expert determining the final answer.\n\n                ### Instructions:\n                - Use standard medical knowledge as the primary guide.\n                - Consider enhanced information only if it aligns with consensus.\n                - If conflicting or unclear, present the most likely correct answer based on known facts.\n                - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n            ### Question    \n            Propronolol is useful in all except -\n\n            ### Options\n            opa. Atrial flutter\nopb. Parkinsonian tremor\nopc. Thyrotoxicosis\nopd. HOCM\n\n### Reasoning Chains for Validation:\n- CHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases heart rate and contractility\" -> \"useful in atrial flutter\" -> 95%\n- CHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases tremors\" -> \"useful in Parkinsonian tremor\" -> 80%\n- CHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"blocks beta receptors\" -> \"reduces symptoms of thyrotoxicosis\" -> \"useful in thyrotoxicosis\" -> 90%\n- CHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"decreases heart rate and contractility\" -> \"may worsen outflow obstruction\" -> \"not useful in HOCM\" -> 85%\n\n### Retrieved Validation Paths:\n- (Tremor)-CAUSES->(Parkinsonian tremor)\n\n            ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n            "
    }
  ],
  "response": "### Core Medical Principle:\nPropranolol is a non-selective beta-blocker that affects the sympathetic nervous system by blocking beta-adrenergic receptors. This action leads to a decrease in heart rate, contractility, and tremor amplitude, among other effects. The drug's utility in various conditions depends on these primary actions.\n\n### Analysis of Options:\n1. **Atrial Flutter (opa)**: Propranolol is effective in managing atrial flutter primarily due to its ability to decrease heart rate and suppress abnormal cardiac rhythms. This aligns well with its pharmacological profile.\n\n2. **Parkinsonian Tremor (opb)**: While primarily a cardiovascular drug, propranolol can reduce tremors, including those associated with Parkinson's disease. This is due to its effect on the sympathetic nervous system, although it is not the primary treatment for Parkinsonian symptoms.\n\n3. **Thyrotoxicosis (opc)**: Propranolol is beneficial in thyrotoxicosis as it helps manage symptoms like tachycardia and anxiety, common in thyroid hormone excess. It does not treat the underlying thyroid dysfunction but is useful symptomatically.\n\n4. **Hypertrophic Obstructive Cardiomyopathy (HOCM) (opd)**: In HOCM, the primary concern is the obstruction of blood flow from the left ventricle. Propranolol, by reducing contractility, could theoretically worsen the degree of obstruction. Therefore, it is generally not recommended in HOCM, where other treatments that do not decrease contractility are preferred.\n\n### Conclusion:\nBased on the pharmacological effects of propranolol and its implications in various medical conditions, it is clear that propranolol is not typically useful in the management of Hypertrophic Obstructive Cardiomyopathy (HOCM) due to the potential to exacerbate the obstruction. This conclusion is supported by the understanding of the drug's action on heart contractility and the pathophysiology of HOCM.\n\n### Final Output:\n```json\n{\n  \"final_analysis\": \"Propranolol, as a non-selective beta-blocker, is effective in conditions like atrial flutter, Parkinsonian tremor, and thyrotoxicosis by reducing heart rate and tremors. However, in Hypertrophic Obstructive Cardiomyopathy (HOCM), its action on decreasing heart contractility can worsen the condition by increasing the obstruction, making it not useful in this specific scenario.\",\n  \"answer\": \"opd\",\n  \"confidence\": 85\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}